RecallGuide.ca
    Health productsUpdated Jan 21, 2026Official source

    Unauthorized GLP-1 drugs in Canada: serious health risks

    Share:

    In plain language

    This recall involves unauthorized and counterfeit versions of GLP-1 drugs, such as semaglutide and tirzepatide, sold in Canada. They are being recalled because they have not been assessed for safety, effectiveness, or quality by Health Canada and could pose serious health risks. Stop using these products and only buy prescription drugs from a licensed pharmacy.

    What to do

    • Stop using unauthorized GLP-1 products immediately.
    • Only buy prescription drugs from a licensed pharmacy.
    • Look for an eight-digit Drug Identification Number (DIN) on authorized products.
    • Speak with your healthcare professional if you have used an unauthorized GLP-1 product and have concerns.
    • Report any health product-related side effects or complaints to Health Canada.

    Get alerts for recalls like this

    Get email alerts when new recalls affect products in this category.

    Categories (optional)

    No spam. Unsubscribe anytime. We only email when there's a relevant recall.

    Affected products

    • Unauthorized and counterfeit versions of GLP-1 receptor agonist drugs (e.g., semaglutide, tirzepatide)

    Why this matters

    Serious health risks due to unassessed ingredients or manufacturing

    Do I have this product?

    This recall only applies to specific products. Follow the steps below to check.

    1. 1

      Check the product name

      Make sure your product name matches one of the affected products listed above.

    If your product matches one or more of the details above, it may be affected by this recall.

    If your product does not match these details, it is not affected by this recall.

    When in doubt, always check the official notice.

    Want alerts if similar products are recalled in Canada?

    Frequently Asked Questions

    Why was this product recalled?

    Serious health risks due to unassessed ingredients or manufacturing

    What should consumers do?

    Stop using unauthorized GLP-1 products immediately. Only buy prescription drugs from a licensed pharmacy. Look for an eight-digit Drug Identification Number (DIN) on authorized products. Speak with your healthcare professional if you have used an unauthorized GLP-1 product and have concerns. Report any health product-related side effects or complaints to Health Canada.

    Where was the product sold?

    This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.

    Is there a health risk?

    Yes, there may be a health risk. Serious health risks due to unassessed ingredients or manufacturing

    When was this product recalled?

    This product was recalled on January 21, 2026.